This study looked at two thymus‑related peptides in young cows and how they change when the ovaries are removed or when estrogen is added. It found that one peptide (beta‑4) drops and then rises around puberty regardless of hormones, while the other (alpha‑1) shows bigger spikes as the animals age and is lowered when estrogen is present. The work is done in cattle, not people, and doesn’t give any dosage or treatment advice for humans.
Weindruch. R R; Naylor. P H PH; Goldstein. A L AL; Walford. R L RL
In mice, the natural level of thymosin‑alpha‑1 is high when they are very young (about 3 weeks old) and then drops sharply by two months, staying relatively low afterward. Cutting calories (dietary restriction) doesn’t change this early drop and only sometimes lowers the already low levels later in life. The study shows that age, not diet, is the main driver of thymosin‑alpha‑1 levels in this mouse strain.
Wolfe. M W MW; Vakharia. D D DD; Wise. T H TH; Kinder. J E JE
In cows, the natural hormones thymosin‑alpha‑1 and thymosin‑beta‑4 spike when the animal is in heat and actually gets pregnant, stay low before puberty unless the cow never gets pregnant (then they rise), and then gradually fall during early pregnancy. The study just measured these changes; it didn’t test giving the peptides to improve health.
Wolf. G T GT; Hudson. J J; Peterson. K A KA; Poore. J A JA; McClatchey. K D KD
This lab study looked at immune cells from people with advanced head‑and‑neck cancer and found they had fewer IL‑2 receptors than healthy people. Adding the peptide thymosin‑alpha‑1 in the dish actually lowered the number of IL‑2‑receptor‑positive cells for a while, but by day four the levels were the same as before. The peptide’s effect wasn’t because it stopped cells from dividing.
Naylor. P H PH; Naylor. C W CW; Badamchian. M M; Wada. S S; Goldstein. A L AL; Wang. S S SS; Sun. D...
The study shows that antibodies made against the natural peptide thymosin‑alpha‑1 can block HIV in lab cells, and a synthetic 30‑amino‑acid piece (called HGP‑30) can trigger similar antibodies that target a key HIV protein, suggesting it could help develop a vaccine or a test for early infection. However, this work is focused on HIV research, not on everyday health or performance, and it doesn’t provide clear guidance for personal use.
Welch. R A RA; Mutchnick. M G MG; Weller. F E FE; Sokol. R J RJ
The study measured thymosin‑alpha‑1, an immune‑modulating peptide, in mothers and newborns around birth and found that both have higher levels than typical adults, with newborns having the highest. However, the levels didn’t change with pregnancy stage and the link between mother and baby levels was unclear, so there’s no clear guidance for using this peptide in health‑hacking protocols.
Scientists made special lab antibodies that specifically stick to the peptide thymosin‑alpha‑1 and used them to show that this peptide is mainly made in the middle part of the thymus gland. The work is a technical advance for research, but it doesn’t give new tips on how to take or use thymosin‑alpha‑1 for health.
Scientists isolated a liver receptor that normally binds the hormone VIP and showed it still works after extraction. The receptor strongly prefers VIP over other similar molecules, and it only weakly binds thymosin‑alpha‑1. This study is mainly about the receptor’s chemistry, not about using thymosin‑alpha‑1 for health benefits.
Scientists looked at special cells in the human thymus called nurse cells and found they surround developing immune cells and naturally contain the peptide thymosin‑alpha‑1, but the study doesn’t tell us how to use this peptide for health or performance.
Naylor. P H PH; Friedman-Kien. A A; Hersh. E E; Erdos. M M; Goldstein. A L AL
The study measured two immune‑related peptides, thymosin‑alpha‑1 and thymosin‑beta‑4, in blood from healthy people, newborns, homosexual men, and AIDS patients, finding that their levels vary independently and are often higher in AIDS, especially thymosin‑alpha‑1.
The study shows that three important thymus hormones – thymulin, thymopoietin, and thymosin‑alpha‑1 – are all made by the same type of cells (the epithelial cells) in both healthy and diseased human thymuses.
In lab tests, thymosin‑alpha‑1 didn’t change antibody production in healthy people, and in patients with primary biliary cirrhosis it actually made their already low antibody output even lower, so it isn’t a useful immune‑boosting supplement for most folks.
Witherspoon. R P RP; Hersman. J J; Storb. R R; Ochs. H H; Goldstein. A L AL; McClure. J J; Noel. D D...
In a small study of bone‑marrow transplant patients, giving thymosin fraction 5 (which contains thymosin‑α1) did not speed up the recovery of the immune system and didn’t change rates of graft‑versus‑host disease, infections, or cancer relapse. It was well‑tolerated, but showed no clear benefit for immune reconstitution.
Pan. L X LX; Haritos. A A AA; Wideman. J J; Komiyama. T T; Chang. M M; Stein. S S; Salvin. S B SB; H...
Scientists figured out the exact building blocks of the human protein prothymosin‑alpha, which includes the short peptide thymosin‑alpha‑1 at its start, and found it’s slightly shorter and a bit different from the rat version, making it less effective in mouse infection tests.
Suh. B Y BY; Naylor. P H PH; Goldstein. A L AL; Rebar. R W RW
The study looked at how estrogen affects two thymus‑derived peptides. It found that estrogen lowers the blood level of thymosin beta‑4 but does not change thymosin‑alpha‑1 levels. The effect was seen in women without natural estrogen and those taking estrogen supplements.
The abstract talks about how hepatitis C has been treated with interferon drugs, sometimes combined with ribavirin, and mentions newer versions like pegylated interferon that work better and are easier to take. It also says that a peptide called thymosin‑alpha‑1 (thymalfasin) is being studied as an extra immune‑boosting add‑on, but there are no details on how well it works or how to use it.
Weller. F E FE; Mutchnick. M G MG; Keren. D F DF; Goldstein. A L AL; Naylor. P H PH
The paper introduces a tiny lab test (microELISA) that can accurately measure the amount of thymosin‑alpha‑1 in a blood sample, but it doesn’t give any advice on how to take the peptide or what effects to expect.
Mutchnick. M G MG; Keren. D F DF; Weller. F E FE; McClure. J E JE; Goldstein. A L AL
The paper describes a lab test (microELISA) that can accurately measure very tiny amounts of the peptide thymosin‑alpha‑1, down to 100 pg/ml, using a specific rabbit antibody. It’s a technical method for researchers, not a guide for dosing or using the peptide in everyday health protocols.
Rubinstein. A A; Novick. B E BE; Sicklick. M J MJ; Bernstein. L J LJ; Incefy. G S GS; Naylor. P H PH...
In kids with AIDS, a hormone called thymulin was low before their immune cells dropped, while another molecule, thymosin‑alpha‑1, was unusually high. Giving a thymosin‑based drug helped a little but only for a short time.
Thymosin‑alpha‑1 can attach to the same receptors that VIP uses, but it does so far weaker and only partially activates them, acting more like a mild, partial copy of VIP rather than a strong substitute.